Results 241 to 250 of about 447,676 (302)
Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement.
J Clin Endocrinol MetabManiatis A +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Indian Journal of Pediatrics, 2005
Growth hormone (GH) therapy has revolutionized treatment of children with growth hormone deficiency (GHD). Improved height outcome with final height in the target height range has been achieved in these children. Identification of Creutzfeldt-Jakob disease, a deadly prion mediated disorder, in recipients of pituitary GH accelerated the transition from ...
Anurag, Bajpai, P Sn, Menon
openaire +2 more sources
Growth hormone (GH) therapy has revolutionized treatment of children with growth hormone deficiency (GHD). Improved height outcome with final height in the target height range has been achieved in these children. Identification of Creutzfeldt-Jakob disease, a deadly prion mediated disorder, in recipients of pituitary GH accelerated the transition from ...
Anurag, Bajpai, P Sn, Menon
openaire +2 more sources
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2007
Growth hormone (GH) is a polypeptide secreted by somatotropic cells of the anterior part of the hypophysis. Its usage was firstly restricted to children with growth hormone deficiency. Because of molecular biology development and greater availability of GH, the range of its therapeutic applications has widened. Apart from supplementary management of GH
Robert, Krysiak +2 more
openaire +3 more sources
Growth hormone (GH) is a polypeptide secreted by somatotropic cells of the anterior part of the hypophysis. Its usage was firstly restricted to children with growth hormone deficiency. Because of molecular biology development and greater availability of GH, the range of its therapeutic applications has widened. Apart from supplementary management of GH
Robert, Krysiak +2 more
openaire +3 more sources
European Journal of Pediatrics, 1989
Seven children with growth hormone deficiency of hypothalamic origin responded to an i.v. bolus of growth hormone releasing hormone (GHRH) (1-29)-NH2 with a mean serum increase of 10.7 ng/ml growth hormone (GH) (range 2.5-29.3 ng/ml). Continuous s.c.
O, Butenandt, B, Staudt
openaire +2 more sources
Seven children with growth hormone deficiency of hypothalamic origin responded to an i.v. bolus of growth hormone releasing hormone (GHRH) (1-29)-NH2 with a mean serum increase of 10.7 ng/ml growth hormone (GH) (range 2.5-29.3 ng/ml). Continuous s.c.
O, Butenandt, B, Staudt
openaire +2 more sources
Growth hormone therapy for adult growth hormone deficiency
Trends in Endocrinology & Metabolism, 1996GH deficiency in adult life is associated with a number of adverse biological changes including osteopenia, reduced exercise capacity, altered body composition, deleterious alterations in the lipid profile and insulin status, and reduced quality of life. Potentially, most of these changes can be reversed by GH replacement therapy.
S M, Shalet, A, Rahim, A A, Toogood
openaire +2 more sources